NCT05725720View on ClinicalTrials.gov

Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Diffuse Large B Cell Lymphoma
Interventions
OTHER

Gut microbiome analysis

Characterization of the compositional and functional modifications of gut microbiome in patients affected by lymphoma undergoing therapy with CAR-T cells from baseline until the restaging after 18 months from the CAR-T cell infusion

Trial Locations (1)

40138

RECRUITING

"Institute Of Hematology Seràgnoli", Bologna

All Listed Sponsors
collaborator

Associazione Italiana per la Ricerca sul Cancro

OTHER

collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

lead

University of Bologna

OTHER